Narciclasine - A Potential Anticancer Drug

Yu Bin Ji; Chun Hui Song; Ning Chen; Dong Xue Song; Yan Dong; Jia Zheng; Bai Feng Wang

doi:10.4028/www.scientific.net/AMM.411-414.3154

Paper Titles

Experimental Study on the Coupling Properties of Force and Magnetic of Giant Magnetostrictive Actuator
p.3134

Traditional Chinese Medicine Based on Network Pharmacology
p.3141

Selenylation, Characterization and Cytotoxic Activity of Seleno-Astragalus Polysaccharide
p.3146

Isocarbostyril Alkaloids and their Derivatives as Promising Antitumor Agents
p.3150

Narciclasine - A Potential Anticancer Drug
p.3154

Structure-Activity Relationship of Two Typical Amaryllidaceae Isocarbostyril Alkaloids and their Derivatives
p.3158

Effects of Dauricine Concentration in Asiatic Moonseed by Different Extraction Solvents and Methods
p.3162

The Decontamination Effect on CS Stimulant with Potassium Permanganate Solution
p.3166

Effect of SO₂ Interval Fumigation on Storage Quality of Red Grape
p.3170

HomeApplied Mechanics and MaterialsApplied Mechanics and Materials Vols. 411-414Narciclasine - A Potential Anticancer Drug

Narciclasine - A Potential Anticancer Drug

Abstract:

Narciclasine (NCS) is a plant growth inhibitor isolated from the secreted mucilage of Narcissus tazetta bulbs, which is commonly used anticancer agent in human systems. Refer to the literatures in recent years, this article reviewed the anti-cancer effects of potential anticancer drugsNarciclasine, which induces apoptosis by activation of the death receptor and/or mitochondrial pathways in cancer cells. Narciclasine displays antitumor effects in apoptosis-resistant as well as in apoptosis-sensitive cancer cells by impairing the organization of the actin cytoskeleton.

You might also be interested in these eBooks

View Preview

Info:

Periodical:

Applied Mechanics and Materials (Volumes 411-414)

Pages:

3154-3157

DOI:

https://doi.org/10.4028/www.scientific.net/AMM.411-414.3154

Citation:

Cite this paper

Online since:

September 2013

Authors:

Yu Bin Ji, Chun Hui Song, Ning Chen, Dong Xue Song, Yan Dong, Jia Zheng, Bai Feng Wang*

Keywords:

Anti-Tumor, Mechanism, Narciclasine, Potential Anticancer Drugs

Export:

RIS, BibTeX

Price:

Permissions CCC:

Request Permissions

Permissions PLS:

Request Permissions

Сopyright:

Citation:

* - Corresponding Author

References

[1] J.N. Jerald, L. Rarova, M. Strnad, et al. Bioorganic and Medicinal Chemistry Letters. Vol. 22 (2012), p.6195–6199.

Google Scholar

[2] B. Weniger, L. Italiano, J.P. Beck, et al. Planta Med. Vol. 61(1995), pp.77-79.

Google Scholar

[3] F. Piozzi, L. Marino, C. Fuganti et al. Phytochemistry. Vol. 8 (1969), p.1745–1748.

Google Scholar

[4] L. Ingrassia, F. Lefranc, V. Mathieu, et al. Translational Oncology. Vol. 1 (2008), pp.1-13.

Google Scholar

[5] G. Ceriotti: Nature. Vol. 213 (1967), p.595–596.

Google Scholar

[6] P. Dumont, L. Ingrassia, S. Rouzeau, et al. Neoplasia. Vol. 9 (2007), pp.766-776.

Google Scholar

[7] L. Ingrassia, F. Lefranc, J. Dewelle, et al. Med. Chem. Vol. 52 (2009), p.1100–1114.

Google Scholar

[8] M. Ghosh, X. Song, G. Mouneimne, et al. Science. Vol. 304 (2004), p.743–746.

Google Scholar

[9] C.T. Yap, T.I. Simpson, T. Pratt, et al. Cell Motil Cytoskeleton. Vol. 60 (2005), p.153–165.

Google Scholar